CI Trademark

Trademark Overview


On Thursday, January 8, 2026, a trademark application was filed for CI with the United States Patent and Trademark Office. The USPTO has given the CI trademark a serial number of 99583495. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 8, 2026. This trademark is owned by Somite Therapeutics, Inc.. The CI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Engineering of biological cells and tissues; Development of computer platforms for cell and tissue modeling, simulation, data generation and predictive analysis; Advanced product research, design and development in the field of software for cellular modeling and predictive analysis for discovery and development of cell therapies and regenerative medicines; Technology consultation in the field of software for scientific and medical research, namely, cellular modeling and predictive analysis; Scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, all for cellular modeling, simulation and predictive analysis; Software as a service (SaaS) featuring software for generating visualizations, insights and reports that enable the user to analyze and modify results and make changes to the core dataset and for selecting and altering predictive models in the fields o...
ci

General Information


Serial Number99583495
Word MarkCI
Filing DateThursday, January 8, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, January 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesEngineering of biological cells and tissues; Development of computer platforms for cell and tissue modeling, simulation, data generation and predictive analysis; Advanced product research, design and development in the field of software for cellular modeling and predictive analysis for discovery and development of cell therapies and regenerative medicines; Technology consultation in the field of software for scientific and medical research, namely, cellular modeling and predictive analysis; Scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, all for cellular modeling, simulation and predictive analysis; Software as a service (SaaS) featuring software for generating visualizations, insights and reports that enable the user to analyze and modify results and make changes to the core dataset and for selecting and altering predictive models in the fields of cellular engineering, cellular therapy, immunotherapy and regenerative medicine; Testing of computing methods, computer software algorithms, computer software, and computer hardware for cell structure modeling and prediction; Software as a service (SAAS) services featuring software for cell structure prediction, modeling, analysis, and data generation
Description of MarkThe mark consists of the stylized letters "CI".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 8, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSomite Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events


Event DateEvent Description
Thursday, January 8, 2026NEW APPLICATION ENTERED
Thursday, January 8, 2026APPLICATION FILING RECEIPT MAILED